Basics Rein Therapeutics, Inc. Common Stock IPO Date: August 26, 2021 Sector: Healthcare Industry: Biotech Market Cap: $35.75M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 4.54% Avg Daily Range (30 D): $0.06 | 4.02% Avg Daily Range (90 D): $0.05 | 4.09% Institutional Daily Volume Avg Daily Volume: .05M Avg Daily Volume (30 D): 1.22M Avg Daily Volume (90 D): .49M Trade Size Avg Trade Size (Sh.): 145 Avg Trade Size (Sh.) (30 D): 130 Avg Trade Size (Sh.) (90 D): 141 Institutional Trades Total Inst.Trades: 2 Avg Inst. Trade: $.63M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.63M Avg Inst. Trade Volume: .5M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Aug 19, 2025 @ 12:00 PM Rein Therapeutics Wins U.K. Approval to Launch Pha... Source: Rein Therapeutics Aug 14, 2025 @ 9:00 PM Rein Therapeutics to Present Novel IPF Science and... Source: Rein Therapeutics Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.21 $-.28 $-.25 Diluted EPS $-.21 $-.28 $-.25 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -5.58M $ -6.82M $ -5.5M Operating Income / Loss $ -5.49M $ -6.87M $ -5.61M Cost of Revenue $ $ $ Net Cash Flow $ .03M $ M $ M PE Ratio